Total planned funding: $337,865,115
Clear active filters
Unknown
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $85,854,639 |
Tanzania | $49,228,566 |
Nigeria | $30,437,603 |
Uganda | $29,033,059 |
Haiti | $21,469,157 |
Kenya | $20,130,914 |
Zambia | $17,339,553 |
Zimbabwe | $12,211,012 |
Burundi | $8,629,493 |
Democratic Republic of the Congo | $7,842,732 |
Mozambique | $6,997,511 |
Vietnam | $6,602,310 |
Cameroon | $4,831,720 |
Ethiopia | $4,667,035 |
Cambodia | $4,659,203 |
Malawi | $4,302,800 |
Ghana | $4,200,000 |
Central Asia Region | $3,800,000 |
India | $2,850,000 |
Namibia | $2,842,812 |
Ukraine | $2,549,500 |
Central America Region | $2,080,931 |
Botswana | $1,430,000 |
Lesotho | $1,300,000 |
South Sudan | $929,565 |
Côte d'Ivoire | $600,000 |
Rwanda | $520,000 |
Angola | $375,000 |
Caribbean Region | $150,000 |
Organizational Types
Unknown | $337,865,115 |
Program Areas
Prevention | $110,967,522 |
Care | $99,045,438 |
Governance and Systems | $75,630,920 |
Treatment | $35,859,901 |
Testing | $24,600,672 |
Budget Codes
HKID: Care: Orphans and Vulnerable Children | $68,558,549 |
HVOP: Sexual Prevention: Other Sexual Prevention | $41,210,680 |
OHSS: Health Systems Strengthening | $32,775,110 |
HVSI: Strategic Information | $31,551,239 |
HTXS: Treatment: Adult Treatment | $27,741,955 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $26,142,967 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $24,874,477 |
HVCT: Testing: HIV Testing and Counseling | $24,600,672 |
HBHC: Care: Adult Care and Support | $21,302,924 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,086,308 |
HLAB: Laboratory Infrastructure | $11,304,571 |
HVTB: Care: TB/HIV | $6,293,322 |
PDTX: Treatment: Pediatric Treatment | $5,917,946 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,059,940 |
PDCS: Care: Pediatric Care and Support | $2,890,643 |
HTXD: Treatment: ARV Drugs | $2,200,000 |
HMBL: Biomedical Prevention: Blood Safety | $1,512,284 |
HMIN: Biomedical Prevention: Injection Safety | $80,866 |